Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 27 February 1998:
Vol. 279. no. 5355, pp. 1307 - 1308
DOI: 10.1126/science.279.5355.1307b
Prev | Table of Contents | Next

News

AAAS MEETING:
10-Gallon Molecule Stomps Tumors

Amy Adams

A newly created, larger version of a pigment called porphyrin that ferries iron and other metals in the blood is showing promise as a means of ferrying cancer drugs into tumor cells. In pilot trials, the new molecule, called texaphyrin, has shown promise in enhancing the effects of radiation on inoperable brain tumors, and the National Cancer Institute has now added it to its list of the most promising therapies.

Read the Full Text

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)